About Resolution Bioscience
Resolution Bioscience is a Healthcare company based in Kirkland (United States) founded in 2012, and was acquired by Exact Sciences in September 2023. Blood-based cancer diagnostics are developed via next-generation sequencing. The company has 89 employees. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its competitors include Guardant Health, GRAIL and Foundation Medicine; 3 of its 3 listed competitors have raised funding.
Company details
Resolution Bioscience was founded in 2012 in Kirkland, United States, within the biotechnology sector focused on oncology. Blood samples are analyzed for circulating tumor DNA using next-generation sequencing and proprietary bioinformatics tools. A liquid biopsy assay for Anaplastic lymphoma kinase alterations serves as the flagship product. Validation efforts are underway for non-small cell lung cancer assays, alongside custom molecular assays for research applications.
- Headquarters Kirkland, United States
- Employees 89
- Stage Acquired
- SectorsHealthcare
- Website resolutionbio.com
- Social LinkedIn
- Acquired by Agilent (Mar 2021)
- InvestorsExact Sciences
& 1 more
- Employee Count89
- Acquired by
Investors in Resolution Bioscience
Resolution Bioscience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Exact Sciences and Agilent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Non-invasive molecular diagnostic tests for cancer detection are provided. | 1995 | exactsciences.com | Madison, United States | |
Diversified instruments are developed for scientific and laboratory management. | 1995 | agilent.com | Santa Clara, United States |
Investor details for Resolution Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Resolution Bioscience
16 people are tracked at Resolution Bioscience (1 in leadership, 15 in team); the tracked headcount is 89.
| Name | Role | Group |
|---|---|---|
Frazer Meacham | Associate Director, Computational Biology | Leadership |
Kevin Lau | Software Engineer | Team |
Matthew Spaziani | Lab Automation and Process Development Engineer | Team |
Ron Newcomb | Senior Software Developer | Team |
Jeremy Banks | Sr. DevOps Engineer | Team |
Kunlun Tan | Software Development Manager / Senior Software Engineer II | Team |
Mei Huang | Senior Quality Engineer | Team |
Paris Chávez | Senior Software Engineer in Test (SDET) | Team |
Arthur Lee | Design Control Project Manager | Team |
Sara Nasser | Computational Biologist | Team |
Ashley Berkebile | Scientist II | Team |
Christopher C. | Clinical QA Specialist | Team |
Gary Painchaud | Equipment Engineer | Team |
Carolyn Hutcheon | Scientist | Team |
Paul Stull | Senior Scientist | Team |
Brian P. | Sr Technical Program Manager | Team |
Complete people profiles for Resolution Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Resolution Bioscience
3 dated milestones of Resolution Bioscience across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Resolution Bioscience is founded.
- Exit Acquired by Agilent.
- Exit Acquired by Exact Sciences.
Competitors of Resolution Bioscience
Resolution Bioscience has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, GRAIL and Foundation Medicine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| grail.com | 2016 | Menlo Park, United States | $2B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. |
Detailed competitors of Resolution Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Resolution Bioscience
The website of Resolution Bioscience (resolutionbio.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 13% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Resolution Bioscience (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Resolution Bioscience
Complete news archive for Resolution Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Resolution Bioscience
Resolution Bioscience was founded in 2012.
Resolution Bioscience is headquartered in Kirkland, United States. It is registered at Kirkland, Washington, United States.
Resolution Bioscience has 89 employees.
Resolution Bioscience was founded in 2012 in Kirkland, United States, within the biotechnology sector focused on oncology. Blood samples are analyzed for circulating tumor DNA using next-generation sequencing and proprietary bioinformatics tools. A liquid biopsy assay for Anaplastic lymphoma kinase alterations serves as the flagship product. Validation efforts are underway for non-small cell lung cancer assays, alongside custom molecular assays for research applications.
Resolution Bioscience's top competitors include Guardant Health, GRAIL and Foundation Medicine.
Resolution Bioscience has 2 investors. Key investors include Exact Sciences, and Agilent.
Yes. Resolution Bioscience was acquired by Agilent in March 2021.